FDA Approves First Drug Shown to Slow Down Alzheimer’s Progression
The Alzheimer's drug Leqembi recently received full approval from the Food and Drug Administration (FDA), marking the first drug to ...
Read moreThe Alzheimer's drug Leqembi recently received full approval from the Food and Drug Administration (FDA), marking the first drug to ...
Read moreUpdated January 7, 2023. For many, the last three years, 2020-2022 have been simply dismal, dominated by the Covid pandemic. ...
Read moreBrain and mental disease act differently on different people, and a broad range of factors account for the differences. Clinical ...
Read moreImpakter informs you through the eco news site and empowers your sustainable lifestyle with its eco products marketplace.
Registered Office Address
32 Lots Road, London
SW10 0QJ, United Kingdom
IMPAKTER Limited
Company number: 10806931
Impakter is a publication that is identified by the following International Standard Serial Number (ISSN) is the following 2515-9569 (Printed) and 2515-9577 (online – Website).
Office Hours - Monday to Friday
9.30am - 5.00pm CEST
stories [at] impakter.com
© 2024 IMPAKTER. All rights reserved.